Floatz logo

2-(1-HEXYLOXYETHYL)-2-DEVINYLPYROPHEOPHORBIDE-A

Lung Non-Small Cell Carcinoma

Roswell Park Cancer InstituteSmall moleculePhase 1Active
CCC
50/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
40/ 100
Competitive Position
81/ 100

Competitive context

22 Active assets in the Lung Non-Small Cell Carcinoma cohort.

Asset / SponsorPhaseRating
FLUDEOXYGLUCOSE
Alliance for Clinical Trials in Oncology
Phase 3BB
Montanide Isa 51
Roswell Park Cancer Institute
Phase 3BB
Recombinant Human EGF-rP64K
Roswell Park Cancer Institute
Phase 2BB
Recombinant Human Hyaluronidase
National Cancer Institute (NCI)
Phase 3BB
MITOMYCIN C
City of Hope Medical Center
Phase 3B

View all 24 →

Same molecule, other indications

2-(1-HEXYLOXYETHYL)-2-DEVINYLPYROPHEOPHORBIDE-A is also rated in:

Liver NeoplasmsDormant
B
Indicative ·
62 / 100
View asset →
Stage II Pancreatic Cancer AJCC v8Dormant
B
Indicative ·
59 / 100
View asset →
Liver MetastasisDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →